China Pharma Holdings, Inc.
CPHI
$0.65
-$0.01-1.39%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.70% | 32.76% | 16.97% | -28.31% | -53.84% |
| Total Depreciation and Amortization | -41.01% | -47.20% | -34.99% | -19.06% | -2.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,959.42% | 11.47% | 10.28% | 250.55% | 2,013.36% |
| Change in Net Operating Assets | 1,144.76% | 112.42% | 25.05% | 139.96% | 401.51% |
| Cash from Operations | 136.52% | 140.58% | 48.30% | -33.86% | 41.95% |
| Capital Expenditure | -54.43% | -234.62% | -72.98% | -740.87% | -233.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.25% | -- | -- | -- | -- |
| Cash from Investing | 52.95% | -1,628.21% | -254.25% | -452.30% | -2,437.39% |
| Total Debt Issued | 84.79% | -83.50% | -35.04% | -50.23% | -66.73% |
| Total Debt Repaid | -126.59% | 64.89% | 41.80% | 57.67% | 62.83% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -101.45% | -- |
| Cash from Financing | -772.40% | -640.59% | 66.06% | 74.76% | -146.10% |
| Foreign Exchange rate Adjustments | 101.98% | -236.65% | -330.52% | -1,006.90% | -305.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.64% | 30.72% | 29.66% | -29.91% | -31.50% |